UBALD2 antibodies are immunoglobulin proteins designed to specifically bind to epitopes within the UBALD2 protein. Key features include:
UBALD2 antibodies are validated for use in multiple experimental workflows:
Immunohistochemistry (IHC): Detects UBALD2 expression in formalin-fixed, paraffin-embedded tissues .
Western Blot (WB): Identifies UBALD2 in lysates with minimal cross-reactivity .
Blocking Peptide Studies: Synthetic peptides (e.g., Catalog No. ABIN976580) are used to validate antibody specificity by competitively inhibiting binding .
Key Validation Data:
A polyclonal antibody (Thermo Scientific PA554676) demonstrated reactivity in human samples at a dilution of 1:200 for IHC and 1:1000 for WB .
Antibodies exhibit 86% sequence identity with mouse UBALD2 and 88% with rat orthologs, supporting cross-species studies .
Despite limited functional data, UBALD2’s UBA-like domain implies involvement in ubiquitin-mediated processes, such as protein degradation or signal transduction . Current research highlights:
Protein Interactions: UBALD2 may interact with CCDC85B and KPNA3, though mechanistic studies are lacking .
Disease Relevance: No direct associations with pathologies are reported, but its structural homology to UBA-domain proteins suggests potential roles in cancer or immune regulation .